Celldex Therapeutics (CLDX) Intangibles (2010 - 2026)

Celldex Therapeutics' Intangibles history runs 17 years deep, the most recent figure standing at $27.2 million for Q1 2026.

• On a quarterly basis, Intangibles changed 0.0% year-over-year to $27.2 million in Q1 2026; TTM through Mar 2026 was $27.2 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $27.2 million, changed 0.04% from the prior year.
• Intangibles steadied at $27.2 million in Q1 2026 per CLDX's latest filing, from $27.2 million in the prior quarter.
• Across five years, Intangibles topped out at $27.2 million in Q2 2022 and bottomed at $27.2 million in Q1 2022.
• The 5-year median for Intangibles is $27.2 million (2022), against an average of $27.2 million.
• Biggest YoY gain for Intangibles was 0.04% in 2022; the steepest drop was 11.43% in 2022.
• Year by year, Intangibles stood at $27.2 million in 2022, then changed by 0.0% to $27.2 million in 2023, then changed by 0.0% to $27.2 million in 2024, then slipped by 0.04% to $27.2 million in 2025, then changed by 0.0% to $27.2 million in 2026.
• Per Business Quant, the three latest CLDX Intangibles figures stand at $27.2 million (Q1 2026), $27.2 million (Q4 2025), and $27.2 million (Q3 2025).